loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 125427 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 ADO-TRASTUZUMAB EMTANSINE (2)

filter

01 GENENTECH (2)

filter

01 VIAL; SINGLE-USE (2)

filter

01 100MG (1)

02 160MG (1)

filter

01 USA (2)

URL Supplier Web Content
VIAL; SINGLE-USE
160MG
KADCYLA
USA
125427
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
VIAL; SINGLE-USE
100MG
KADCYLA
USA
125427
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 125427

Looking for CTD TGA MCC DOSSIER APPLICATION 125427 2

19

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ADO-TRASTUZUMAB EMTANSINE, with a corresponding application number 125427 and regulatory information .

proudly manufactured in the

Genentech's KADCYLA VIAL; SINGLE-USE, medication with 160MG of ADO-TRASTUZUMAB EMTANSINE.

18

Genentech, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is ADO-TRASTUZUMAB EMTANSINE, with a corresponding application number 125427 and regulatory information .

proudly manufactured in the

Genentech's KADCYLA VIAL; SINGLE-USE, medication with 100MG of ADO-TRASTUZUMAB EMTANSINE.

Post Enquiry
POST ENQUIRY